# Simon Property Group Inc.: financial statements, quarterly

SPG · NYSE · CIK 1063761 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spg.md) · [Financials](/companies/spg/financials.md) · [Filings](/companies/spg/filings.md) · [Insiders](/companies/spg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,411](/filings/0001558370-25-001271.md) | [1,527](/filings/0001558370-25-001271.md) | [1,443](/filings/0001104659-26-019419.md) | [1,458](/filings/0001104659-26-019419.md) | [1,481](/filings/0001104659-26-019419.md) | [1,582](/filings/0001104659-26-019419.md) | [1,473](/filings/0001104659-26-058640.md) | [1,498](/filings/0001104659-26-093360.md) | [1,602](/filings/0001104659-26-019419.md) | [1,791](/filings/0001104659-26-019419.md) | [1,757](/filings/0001104659-26-058640.md) | [1,791](/filings/0001104659-26-093360.md) |
| Operating income | $m | [694](/filings/0001558370-25-001271.md) | [792](/filings/0001558370-25-001271.md) | [735](/filings/0001104659-26-019419.md) | [754](/filings/0001104659-26-019419.md) | [768](/filings/0001104659-26-019419.md) | [836](/filings/0001104659-26-019419.md) | [728](/filings/0001104659-26-058640.md) | [744](/filings/0001104659-26-093360.md) | [813](/filings/0001104659-26-019419.md) | [891](/filings/0001104659-26-019419.md) | [762](/filings/0001104659-26-058640.md) | [824](/filings/0001104659-26-093360.md) |
| Interest expense | $m | [212](/filings/0001558370-23-017324.md) | [225 d](/filings/0001104659-26-019419.md) | [231](/filings/0001558370-25-007380.md) | [221](/filings/0001558370-25-010639.md) | [226](/filings/0001104659-25-107395.md) | [227 d](/filings/0001104659-26-019419.md) | [227](/filings/0001104659-26-058640.md) | [233](/filings/0001104659-26-093360.md) | [243](/filings/0001104659-25-107395.md) | [272 d](/filings/0001104659-26-019419.md) | [276](/filings/0001104659-26-058640.md) | [281](/filings/0001104659-26-093360.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [681](/filings/0001558370-25-001271.md) | [859](/filings/0001558370-25-001271.md) | [841](/filings/0001104659-26-019419.md) | [569](/filings/0001104659-26-019419.md) | [547](/filings/0001104659-26-019419.md) | [772](/filings/0001104659-26-019419.md) | [478](/filings/0001104659-26-058640.md) | [644](/filings/0001104659-26-093360.md) | [703](/filings/0001104659-26-019419.md) | [3,540](/filings/0001104659-26-019419.md) | [569](/filings/0001104659-26-058640.md) | [574](/filings/0001104659-26-093360.md) |
| Diluted EPS | $ per share | [1.82](/filings/0001558370-25-001271.md) | [2.29](/filings/0001558370-25-001271.md) | [2.25](/filings/0001104659-26-019419.md) | [1.51](/filings/0001104659-26-019419.md) | [1.46](/filings/0001104659-26-019419.md) | [2.04](/filings/0001104659-26-019419.md) | [1.27](/filings/0001104659-26-058640.md) | [1.70](/filings/0001104659-26-093360.md) | [1.86](/filings/0001104659-26-019419.md) | [9.35](/filings/0001104659-26-019419.md) | [1.48](/filings/0001104659-26-058640.md) | [1.49](/filings/0001104659-26-093360.md) |
| Basic EPS | $ per share | [1.82](/filings/0001558370-25-001271.md) | [2.29](/filings/0001558370-25-001271.md) | [2.25](/filings/0001104659-26-019419.md) | [1.51](/filings/0001104659-26-019419.md) | [1.46](/filings/0001104659-26-019419.md) | [2.04](/filings/0001104659-26-019419.md) | [1.27](/filings/0001104659-26-058640.md) | [1.70](/filings/0001104659-26-093360.md) | [1.86](/filings/0001104659-26-019419.md) | [9.35](/filings/0001104659-26-019419.md) | [1.48](/filings/0001104659-26-058640.md) | [1.49](/filings/0001104659-26-093360.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001558370-23-017324.md) | [1.2](/filings/0001558370-25-001271.md) | [1.3](/filings/0001558370-24-007058.md) | [1.2](/filings/0001558370-24-011208.md) | [2.2](/filings/0001558370-24-014946.md) | [1.4](/filings/0001104659-26-019419.md) | [1.4](/filings/0001558370-25-007380.md) | [1.2](/filings/0001558370-25-010639.md) | [1.6](/filings/0001104659-25-107395.md) | [0.8](/filings/0001104659-26-093360.md) | [0.5](/filings/0001104659-26-058640.md) | [1.0](/filings/0001104659-26-093360.md) |
| Total assets | $bn | [33.0](/filings/0001558370-23-017324.md) | [34.3](/filings/0001558370-25-001271.md) | [33.7](/filings/0001558370-24-007058.md) | [33.4](/filings/0001558370-24-011208.md) | [33.3](/filings/0001558370-24-014946.md) | [32.4](/filings/0001104659-26-019419.md) | [32.5](/filings/0001558370-25-007380.md) | [33.3](/filings/0001558370-25-010639.md) | [33.6](/filings/0001104659-25-107395.md) | [40.6](/filings/0001104659-26-093360.md) | [39.6](/filings/0001104659-26-058640.md) | [39.7](/filings/0001104659-26-093360.md) |
| Total liabilities | $bn | [29.4](/filings/0001558370-23-017324.md) | [30.6](/filings/0001558370-25-001271.md) | [29.9](/filings/0001558370-24-007058.md) | [29.8](/filings/0001558370-24-011208.md) | [30.0](/filings/0001558370-24-014946.md) | [28.8](/filings/0001104659-26-019419.md) | [29.2](/filings/0001558370-25-007380.md) | [30.2](/filings/0001558370-25-010639.md) | [30.6](/filings/0001104659-25-107395.md) | [33.9](/filings/0001104659-26-093360.md) | [33.3](/filings/0001104659-26-058640.md) | [33.9](/filings/0001104659-26-093360.md) |
| Long-term debt | $bn | [24.9](/filings/0001558370-23-017324.md) | [26.0](/filings/0001558370-25-001271.md) | [25.5](/filings/0001558370-24-007058.md) | [25.3](/filings/0001558370-24-011208.md) | [25.4](/filings/0001558370-24-014946.md) | [24.3](/filings/0001104659-26-019419.md) | [24.8](/filings/0001558370-25-007380.md) | [25.4](/filings/0001558370-25-010639.md) | [25.8](/filings/0001104659-25-107395.md) | [28.4](/filings/0001104659-26-093360.md) | [28.2](/filings/0001104659-26-058640.md) | [28.7](/filings/0001104659-26-093360.md) |
| Shareholders' equity | $bn | [3.0](/filings/0001558370-23-017324.md) | [3.0](/filings/0001558370-25-001271.md) | [3.1](/filings/0001558370-24-007058.md) | [2.9](/filings/0001558370-24-011208.md) | [2.7](/filings/0001558370-24-014946.md) | [2.9](/filings/0001104659-26-019419.md) | [2.6](/filings/0001558370-25-007380.md) | [2.5](/filings/0001558370-25-010639.md) | [2.3](/filings/0001104659-25-107395.md) | [5.2](/filings/0001104659-26-093360.md) | [4.9](/filings/0001104659-26-058640.md) | [4.4](/filings/0001104659-26-093360.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [936 d](/filings/0001558370-24-014946.md) | [1,037 d](/filings/0001104659-26-019419.md) | [773](/filings/0001558370-25-007380.md) | [1,063 d](/filings/0001558370-25-010639.md) | [893 d](/filings/0001104659-25-107395.md) | [1,086 d](/filings/0001104659-26-019419.md) | [827](/filings/0001104659-26-058640.md) | [1,215 d](/filings/0001104659-26-093360.md) | [890 d](/filings/0001104659-25-107395.md) | [1,204 d](/filings/0001104659-26-019419.md) | [833](/filings/0001104659-26-058640.md) | [1,196 d](/filings/0001104659-26-093360.md) |
| Capital expenditure | $m | [228 d](/filings/0001558370-24-014946.md) | [178 d](/filings/0001104659-26-019419.md) | [163](/filings/0001558370-25-007380.md) | [188 d](/filings/0001558370-25-010639.md) | [186 d](/filings/0001104659-25-107395.md) | [218 d](/filings/0001104659-26-019419.md) | [230](/filings/0001104659-26-058640.md) | [244 d](/filings/0001104659-26-093360.md) | [205 d](/filings/0001104659-25-107395.md) | [255 d](/filings/0001104659-26-019419.md) | [208](/filings/0001104659-26-058640.md) | [237 d](/filings/0001104659-26-093360.md) |
| Share repurchases | $m | not reported | [35.0 d](/filings/0001104659-26-019419.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [175](/filings/0001104659-26-058640.md) | [161 d](/filings/0001104659-26-093360.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [327](/filings/0001558370-25-001271.md) | [326](/filings/0001558370-25-001271.md) | [326](/filings/0001104659-26-019419.md) | [326](/filings/0001104659-26-019419.md) | [326](/filings/0001104659-26-019419.md) | [326](/filings/0001104659-26-019419.md) | [326](/filings/0001104659-26-058640.md) | [326](/filings/0001104659-26-093360.md) | [326](/filings/0001104659-26-019419.md) | [326](/filings/0001104659-26-019419.md) | [325](/filings/0001104659-26-058640.md) | [324](/filings/0001104659-26-093360.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 0 at 2010-03-31, from the cover of the [10-Q filed 2010-05-10](/filings/0001047469-10-004999.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.